Symbol
|
FAMTJB | XWQLTQ | FARYJB | FABEJB | FADHJB | FAIJJB | ZMFLTQ | FAOLJB | FAODJB | FBECJB | RPFAAV | RPFACV | FBIGJB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Barrier Reverse Convertible |
Sous-jacent
|
Pfizer Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) / Pfizer Inc. Basket | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. | Pfizer Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
19.08.2024 | 27.12.2024 | 30.09.2024 | 18.11.2024 | 23.12.2024 | 28.03.2025 | 08.10.2025 | 04.04.2025 | 22.04.2025 | 29.04.2025 | 30.05.2025 | 30.01.2026 | 02.02.2026 |
Ratio | 0,03572 | - | 0,03285 | 0,02968 | 0,02613 | 0,02766 | - | 0,02775 | 0,02635 | 0,02539 | 0,02852 | 0,005896 | 0,03018 |
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
rendement max. p.a. | - | 12,34% | 9,91% | 4,21% | 5,74% | 8,68% | 10,43% | 8,53% | 6,19% | 8,26% | 7,76% | 9,99% | 11,59% |
Demande | 99,65 | 100,34 | 99,45 | 100,35 | 100,55 | 99,30 | 100,01 | 99,25 | 101,15 | 99,60 | 98,70 | 98,70 | 97,15 |
Offre | 100,15 | 101,15 | 99,95 | 100,85 | 101,05 | 99,80 | 100,81 | 99,75 | 101,65 | 100,10 | 99,20 | 99,50 | 97,65 |